Key facts
- This page summarizes Avista Healthcare Partners GP, Ltd.'s Form 4 filing for RVL Pharmaceuticals plc.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2023, 17:04.
Avista Healthcare Partners GP, Ltd. - 15 Aug 2023 Form 4 Insider Report for RVL Pharmaceuticals plc
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 15 Aug 2023
- Net transaction value
- $0
- Reporting owner signature
- Avista Healthcare Partners GP, Ltd. By: /s/ Ben Silbert, Chief Administrative Officer and General Counsel
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Avista Healthcare Partners GP, Ltd. filed Form 4 for RVL Pharmaceuticals plc on 17 Aug 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVLP
transaction
Ordinary Shares
Other
- Transaction value
- Shares
- -23,730,864
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 15 Aug 2023
- Ownership
- By Avista Capital investment fund
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Avista Healthcare Partners GP, Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Represents a pro rata in-kind distribution of Ordinary Shares of the Issuer to partners for no consideration and includes subsequent distributions by such partners to their partners and members.
Footnote F2
Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.